Dominique Costantini
Founder chez OSE IMMUNOTHERAPEUTICS
Provenance du réseau au premier degré de Dominique Costantini
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 | |
| Public Company | Pharmaceuticals: Major | 28 | |
11
| Public Company | Pharmaceuticals: Other | 11 |
| Public Company | Pharmaceuticals: Major | 5 | |
Only For Children Pharmaceuticals SA
4
| Private Company | 4 | |
Smart Immune SAS
 Smart Immune SAS BiotechnologyHealth Technology Smart Immune SAS is a clinical-stage biotechnology company based in Paris, France. Smart Immune is developing Protcell, a thymus-empowered T cell progenitor therapy platform to re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies for all. The French company aims to improve outcomes for patients with life-threatening diseases such as high-risk blood cancers and primary immunodeficiencies. Smart Immune has ongoing collaborations with leading institutions in the EU and the US. Smart101 is already in phase I/II clinical trials in the EU and the US, looking at the acceleration of complete immune recovery in patients fighting cancer and infection and undergoing allogeneic hematopoietic stem cell transplantation. Smart Immune is also developing therapies using gene-modified T cell progenitors through its Protcell platform to provide targeted treatments against cancer, like persistent off-the-shelf CAR T cells. The company is headquartered at Biotech Santé. The company was founded in 2017 by Karine Rossignol, Marina Cavazzana, Isabelle André, with Karine Rossignol as the CEO since 2017.
2
| Holding Company | Biotechnology | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Dominique Costantini via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | General Counsel | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| RENOVARO INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
Les Laboratoires Servier SAS
 Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Altavia France SA
 Altavia France SA Advertising/Marketing ServicesCommercial Services Altavia France SA is an investment holding company with interest in marketing and advertising sector. The company was founded on September 1, 1954 and is headquartered in Saint-Ouen-Sur-Seine, France. | Advertising/Marketing Services | Director/Board Member Director/Board Member | |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
| INSEAD | College/University | Masters Business Admin Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| THERADIAG | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Chairman Chairman | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ESSEC Business School | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Ecole Centrale Lyon | College/University | Undergraduate Degree Undergraduate Degree | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | Chairman Sales & Marketing | |
| Université Catholique de Louvain | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Lyon | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
HRA Pharma Development SARL
 HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Pharmaceuticals: Major | Director/Board Member Founder | |
| PHARNEXT SCA | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
| DEINOVE | Biotechnology | Director of Finance/CFO Director/Board Member | |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
Boehringer Ingelheim France SASU
 Boehringer Ingelheim France SASU Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim France SAS engages in the research, development, marketing, and distribution of pharmaceuticals. The company was founded on October 31, 1986 and is headquartered in Paris, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SENSORION | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
MES SELCHP Ltd.
 MES SELCHP Ltd. Investment ManagersFinance Part of iCON Infrastructure LLP, MES SELCHP Ltd. engages in equity investment. The private company is based in London, UK. Founded in 1999. | Investment Managers | Director/Board Member | |
| ADVICENNE | Pharmaceuticals: Generic | Director/Board Member Chairman Director/Board Member Chief Executive Officer | |
Sanofi-Aventis France SA
 Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Medical Distributors | Director of Finance/CFO Corporate Officer/Principal | |
| CARBIOS | Miscellaneous Commercial Services | President Investor Relations Contact | |
| CNIM ECS Ltd. | Director/Board Member | ||
| Mese Ltd. | Director/Board Member | ||
Diabeloop SAS
 Diabeloop SAS Medical SpecialtiesHealth Technology Diabeloop SAS develops an electronic artificial pancreas for patients suffering from diabetes 1 in order to reduce hypoglycemia. The company was founded on March 24, 2015 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Chairman | |
| PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | Pharmaceuticals: Major | Chairman Founder | |
Ms Medical Synergy SA
 Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Ms Medical Synergy SA develops pharmaceutical products. It provides materials and products for the medical industry. The firm also offers seminars for the pharmaceutical area. The company was founded on February 3, 1986 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Major | Founder Director/Board Member | |
| Artedrone SAS | President Director/Board Member |
Statistiques
Internationale
| France | 35 |
| Etats-Unis | 8 |
| Belgique | 4 |
| Royaume-Uni | 4 |
| Suisse | 3 |
Sectorielle
| Health Technology | 30 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Finance | 4 |
| Government | 2 |
Opérationnelle
| Director/Board Member | 365 |
| Corporate Officer/Principal | 126 |
| Chairman | 88 |
| Independent Dir/Board Member | 71 |
| Chief Executive Officer | 67 |
Relations les plus connectées
| Insiders | |
|---|---|
| Célia Hart | 36 |
| Jean-Paul Prieels | 32 |
| Pierre Armand Morgon | 29 |
| Rémi Droller | 29 |
| Eric Jean Marie Leire | 27 |
| Walter Flamenbaum | 26 |
| Michel Arié | 25 |
| Carol Brosgart | 24 |
| Didier Hoch | 24 |
| Catherine Dunand | 23 |
| Patrick J. Langlois | 23 |
| Alexandre LeBeaut | 22 |
| David Solomon | 22 |
| Piers John Morgan | 18 |
| Denis Biju-Duval | 18 |
- Bourse
- Insiders
- Dominique Costantini
- Connexions Sociétés
